DEALTALK-As drug prices drop, generics makers fight back with deals
July 27, 2017 at 07:00 AM EDT
NEW YORK, July 27 (Reuters) - Generic drug makers are turning to M&A to shield themselves against a concerted effort by U.S. regulators to crack down on steep drug prices.
